clinical trial · NCT06710626
Control of Assistive Devices Via Brain-Computer Interface Technology
Neuralink Corp·N/A·enrolling by invitation·n = 3
Tetraplegia/TetraparesisAmyotrophic Lateral Sclerosis (ALS)QuadriplegiaSpinal Cord Injury (SCI)Spinal Cord Injury CervicalAssistive Robotic Arm
brief summary
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
started
Nov 25, 2024
primary completion
May 25, 2031
completion
May 25, 2031
last updated
Jun 5, 2025
official title
CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol